Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Sleep disorders in multiple sclerosis and their relationship to fatigue.
Gut-associated lymphoid tissue, gut microbes and susceptibility to experimental autoimmune encephalomyelitis.
Structural Brain Network Characteristics Can Differentiate CIS from Early RRMS.
The role of CNS TLR2 activation in mediating innate versus adaptive neuroinflammation.
CRISPR/Cas9 System as an Agent for Eliminating Polyomavirus JC Infection.
Multiple Sclerosis: Methods and Protocols. Preface.
Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses.
[Diagnostic criteria to patients with multiple sclerosis and clinically isolated syndrome].
Validation of a Dutch version of the Actionable 8-item screening questionnaire for neurogenic bladder overactivity in multiple sclerosis: an observational web-based study.
Anxiety and Depressive Symptoms Are Associated With Worse Performance on Objective Cognitive Tests in MS.
Monitoring multiple sclerosis by multimodal evoked potentials: Numerically versus ordinally scaled scoring systems.
Laquinimod (ABR-215062) for the treatment of relapsing multiple sclerosis.
Myelin oligodendrocyte glycoprotein (MOG35-55)-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice.
A telemedicine meditation intervention for people with multiple sclerosis and their caregivers: study protocol for a randomized controlled trial.
Social support and depressive symptoms among caregivers of veterans with multiple sclerosis.
Longitudinal PET imaging for monitoring myelin repair in the spinal cord.
Low myo-inositol indicating astrocytic damage in a case series of NMO.
A Low-Cost Cognitive Rehabilitation With a Commercial Video Game Improves Sustained Attention and Executive Functions in Multiple Sclerosis: A Pilot Study.
Tau protein levels in the cerebrospinal fluid of the patients with multiple sclerosis in an attack period: Low levels of tau protein may have significance, too.
Transcriptomic profile of host response in mouse brain after exposure to plant toxin abrin.
Platelet-Activating Factor Receptors Mediate Excitatory Postsynaptic Hippocampal Injury in Experimental Autoimmune Encephalomyelitis.
Therapeutic options in neuromyelitis optica spectrum disorders.
FDG PET/CT in Acute Tumefactive Multiple Sclerosis Occurring in a Case of Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.
Aerobic and resistance exercise improve walking speed and endurance in people with multiple sclerosis [synopsis].
Development of a Short Version of MSQOL-54 Using Factor Analysis and Item Response Theory.
Pages
« first
‹ previous
…
649
650
651
652
653
654
655
656
657
…
next ›
last »